ASCO Meeting preview – A focus on Lung Cancer in Chicago and new treatments
An upcoming global oncology meeting will highlight many of the promising advances being made in lung cancer treatments, writes Michael McHale
Source: imt.ie
📰 Patrick Forde News
Patrick Forde News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Patrick Forde. Real-time updates on events, politics, business and more.
Innovations Needed and Future Directions in Treatment of NSCLC
Concluding thoughts on data presented at ESMO 2023, and innovations still needed for improved survival of NSCLC—provided by Patrick Forde, MBBCh.
Patrick Forde Post Conference Perspectives Adjuvant Targeted Therapy Docetaxel Chemotherapy Platinum Doublet Chemotherapy Tropion Lung01
Source: ajmc.com
PAPILLON Trial Insights: ESMO 2023
Patrick Forde, MBBCh, discusses advances in EGFR Exon 20 insertion-mutated NSCLC.
Source: ajmc.com
Lessons from LIBRETTO-431 Trial in RET+ NSCLC
An overview of data presented at ESMO 2023 on the LIBRETTO-431 trial of selpercatinib in RET+ NSCLC.
Patrick Forde Post Conference Perspectives Non Squamous Disease Ret Targeted Ret Fusion Oncogene Subtypes
Source: ajmc.com
Expert Insights into NSCLC Unmet Needs
Experts offer concluding insights on unmet needs in NSCLC treatment and the future of patient care.
Salma Jabbour David Carbone Patrick Forde Martin Dietrich Erina Gillaspie Non Small Cell Lung Cancer
Source: ajmc.com
Striking a Balance: Treatment vs Quality of Life for Patients With NSCLC
Panelists discuss balancing aggressive treatment strategies and maintaining the patient’s quality of life.
Patrick Forde David Carbone Non Small Cell Lung Cancer Quality Of Life Pd L1 Patients Treatment Strategies
Source: ajmc.com
Current Standard Treatments for mNSCLC
Experts discuss the current standard treatment options for patients diagnosed with metastatic NSCLC (mNSCLC).
Source: ajmc.com
Enhancing NSCLC Neoadjuvant Therapy
A panel deliberates post-neoadjuvant strategies and data requirements for optimizing immune checkpoint inhibitors in NSCLC neoadjuvant therapy.
David Carbone Martin Dietrich Patrick Forde Non Small Cell Lung Cancer Advanced Disease Early Stage Disease
Source: ajmc.com
Neoadjuvant Therapy in Early NSCLC Treatment
A panel discusses the role of neoadjuvant therapy in the current treatment approach for early stages of NSCLC.
Erina Gillaspie Patrick Forde David Carbone Non Small Cell Lung Cancer Tage Three Disease Neoadjuvant Therapy
Source: ajmc.com
Younger Women Get Lung Cancer at Higher Rates Than Men
Researchers are struggling to understand what is driving the gender disparity in lung cancer cases among people 35 to 54.
Source: nytimes.com